Use of TAK1 Inhibitor to Achieve Glycemic Control in Mammals
AssigneeConnexios Life Sciences Pvt. Ltd.
InventorsAnup Mammen Oommen, Mahesh Kumar Verma, Urvashi Bahadur, Swapnika Ramu
Life of this patent
Estimating the term…
Abstract
The present invention relates to use of inhibitors of TAK-1 for the production of pharmaceutical agents to achieve glycemic control in mammals and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme.
Claims11
A method of using inhibitors of TAK-1 in preparing a medicament for therapy of diseases which are based on loss of glycemic control in mammals.
A method for lowering elevated blood glucose levels in mammals comprising administering at least one oral administration of a therapeutically effective amount of at least one inhibitor of TAK-1 or of TAK-1 enzyme activity.
Dependencies are inferred from the claim text.